Tyco head Kozlowski decides to stay put:
This article was originally published in Clinica
Dennis Kozlowski, the chairman and chief executive officer of Tyco International, has rejected an offer to run Raytheon, one of the largest defence contractors in the US. The Wall Street Journal reported that Mr Kozlowski was happy to continue running his rapidly expanding conglomerate which snapped up 28 companies last year including Sherwood Davis & Geck.
You may also be interested in...
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
Netherlands' Authority for Consumers and Markets has reprimanded a dietary supplements player for purchasing fake followers and likes on social media to exaggerate the popularity of its products. It is the first case of its kind in the country.